MedTrace Logo

Determination of the Effect of Using Virtual Glasses on Pain and Anxiety During IUD Application

NCT07545850 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2026-04-22

No results posted yet for this study

Summary

This randomized controlled experimental study aimed to determine the effect of using virtual glasses during IUD application on pain and anxiety.

The hypotheses of the study were determined as follows. H1-a: Using virtual glasses during IUD application affects the level of pain. H1-b: Using virtual glasses during IUD application affects the level of anxiety.

Conditions

  • Women Health

Interventions

OTHER

virtual reality application

Virtual reality (VR) glasses are used as a midwifery intervention to reduce anxiety, stress, comfort and pain by directing the individual's attention to a different direction. VR glasses are a stress induction method that provides a fictional reality simulation with visual-visual orientation and three-dimensional views that allow the person to experience real-time perspective. Although the purpose of designing VR glasses is the entertainment sector and architectural studies, the use of VR glasses in the medical field has been increasing recently. In clinical areas, VR glasses are used to direct the attention of patients to another direction, reduce anxiety, stress and pain, and provide comfort and convenience. Some studies in the field of obstetrics reveal the positive effect of VR glasses.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-31
Primary Completion
2024-03-31
Completion
2026-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07545850 on ClinicalTrials.gov